Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kusum Gupta

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Biochemical and Biophysical Research Communications|April 4, 2021
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster modelKoen Vandyck, Rana Abdelnabi, Kusum Gupta, et al.
Journal of Medicinal Chemistry|September 2, 2024
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASHKoen Vandyck, David C McGowan, Xuan G Luong, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2017
The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitorsFrançois-René Alexandre, Eric Badaroux, John P Bilello, et al.
Journal of Medicinal Chemistry|November 22, 2024
The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075Sandrine Vendeville, Franck Amblard, Leda Bassit, et al.
Journal of Medicinal Chemistry|June 30, 2025
Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro InhibitorDorothée Bardiot, David C McGowan, Kusum Gupta, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Biochemical and Biophysical Research Communications|April 4, 2021
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster modelKoen Vandyck, Rana Abdelnabi, Kusum Gupta, et al.
Journal of Medicinal Chemistry|September 2, 2024
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASHKoen Vandyck, David C McGowan, Xuan G Luong, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2017
The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitorsFrançois-René Alexandre, Eric Badaroux, John P Bilello, et al.
Journal of Medicinal Chemistry|November 22, 2024
The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075Sandrine Vendeville, Franck Amblard, Leda Bassit, et al.
Journal of Medicinal Chemistry|June 30, 2025
Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro InhibitorDorothée Bardiot, David C McGowan, Kusum Gupta, et al.
Pageof 4